Recombinant Zoster vaccine (CHO cells) (Liviste Biotech)

重组带状疱疹疫苗（CHO细胞）（立维斯德生物）

Report date: 2025/09/15 14:48:06

Base Information

Drug NameRecombinant Zoster vaccine (CHO cells) (Liviste Biotech)

Drug Alias Name重组带状疱疹疫苗(CHO细胞) （复合佐剂）LWSD603复合佐剂疫苗

ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Development/production technology > Genetically engineered subunit vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHerpes Zoster

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesJiangsu Liviste Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Liviste Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsHerpes Zoster

Inactive IndicationsN/A

Other Information

ATC CodeN/A